Does significantly elevated lung shunt fraction (LSF >20%) promote extrahepatic progression in patients with hepatocellular carcinoma treated with radioembolization?

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Michael M. Pan ◽  
Ahmed Gabr ◽  
Ahsun Riaz ◽  
Samdeep Mouli ◽  
Riad Salem ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Shunt Fraction ◽  
Lung Shunt

Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma

2017 ◽  
Vol 40 (8) ◽  
pp. 1213-1222 ◽  
Author(s):  
Joseph Ralph Kallini ◽  
Ahmed Gabr ◽  
Ryan Hickey ◽  
Laura Kulik ◽  
Kush Desai ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Shunt Fraction ◽  
Macroaggregated Albumin ◽  
Lung Shunt

Tc-99m-MAA lung shunt fraction before Y-90 radioembolization is low among patients with non-hepatocellular carcinoma malignancies

2019 ◽  
Vol 40 (11) ◽  
pp. 1154-1157 ◽  
Author(s):  
Mohammad Elsayed ◽  
Jonathan G. Martin ◽  
Alexander Dabrowiecki ◽  
Daryl T. Goldman ◽  
Razan Faraj ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Shunt Fraction ◽  
Lung Shunt

Influence of Time Delay on the Estimated Lung Shunt Fraction on 99mTc-Labeled MAA Scintigraphy for 90Y Microsphere Treatment Planning

2013 ◽  
pp. 1 ◽  
Author(s):  
Ruth De Gersem ◽  
Geert Maleux ◽  
Hubert Vanbilloen ◽  
Kristof Baete ◽  
Chris Verslype ◽  
...  
Keyword(s):  
Time Delay ◽  
Treatment Planning ◽  
Shunt Fraction ◽  
Lung Shunt
Sign in / Sign up

Export Citation Format

Share Document